Myriam Curet McAdams - 28 Jan 2026 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet
Issuer symbol
ISRG
Transactions as of
28 Jan 2026
Net transactions value
-$39,201
Form type
4
Filing time
30 Jan 2026, 21:16:57 UTC
Previous filing
28 Jan 2026
Next filing
11 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curet Myriam EVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 30 Jan 2026 0001632901

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $26,321 +126 $208.90 126 29 Jan 2026 Direct F1
transaction ISRG Common Stock Sale $65,523 -126 -100% $520.02 0 29 Jan 2026 Direct F1
holding ISRG Common Stock 353 28 Jan 2026 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -126 -50% $0.000000 125 29 Jan 2026 Common Stock 126 $208.90 Direct F1, F2
transaction ISRG Performance Stock Units - 2-28-2023 Award $0 +5,585 $0.000000 5,585 28 Jan 2026 Common Stock 5,585 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3 Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.